Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development Publication Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development A new paper argues context of use, not NAMs-versus-animals, should govern nonclinical strategy in drug…Danielle Pillsbury2026年9月9日
From Models to Decisions: Building MIDD Readiness in the Era of ICH M15 Guide From Models to Decisions: Building MIDD Readiness in the Era of ICH M15 Explore what ICH M15 means for Model-Informed Drug Development and learn how to build MIDD…Rik de Greef2026年9月9日
An Introduction to Fast and Reliable Modeling with RsNLME and Agentic AI Live Events An Introduction to Fast and Reliable Modeling with RsNLME and Agentic AI Certara2026年9月1日
A glimpse into the future of model-informed drug discovery and development Publication A glimpse into the future of model-informed drug discovery and development Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…Certara2026年8月28日
Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology Publication Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…Certara2026年8月28日
The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose Webinar The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose Danielle Pillsbury2026年8月28日
De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA) Case Study De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA) Learn how Model-based meta-analysis (MBMA) helped optimize Phase 3 trial design, dose selection, and development…Danielle Pillsbury2026年8月28日
The five drug development questions that bring sponsors to pharmacometrics Blog The five drug development questions that bring sponsors to pharmacometrics Sponsors rarely come to pharmacometrics because they need a model. They come with a development…Rik de Greef2026年8月24日
Beyond Trial and Error: Model-Informed Formulation Development in Practice Webinar Beyond Trial and Error: Model-Informed Formulation Development in Practice Siri Kalyan Chirumamilla2026年8月24日
MBMA data curation: How AI and expert meta-analysts get it right, fast Blog MBMA data curation: How AI and expert meta-analysts get it right, fast In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…Matt Zierhut, PhD MBA2026年8月14日